The canada mammography market size was valued at USD 113.03 million in 2025 and is estimated to grow from USD 121.17 million in 2026 to reach USD 177.28 million by 2031, at a CAGR of 7.91% during the forecast period (2026-2031). This report is Segmented by Technology (Analog Film Mammography, Full-Field Digital Mammography (2D), Digital Breast Tomosynthesis (3D), and More) and End User (Hospitals & Surgical Centres, Dedicated Breast Screening Centres, Diagnostic Imaging Centres, Mobile Screening Units, Ambulatory Care & Specialty Clinics). The Market Forecasts are Provided in Terms of Value (USD).
Hospital buyers in centralized provinces have begun specifying 3D-readiness as the default, whereas in decentralized jurisdictions, units are still procured as cost-optimized 2D units, with upgrades planned later. Saskatchewan’s mobile units illustrate a throughput-first mindset, prioritizing direct radiography and satellite transfer over complex 3D stacks. As a result, the Canada mammography market size for AI-enabled 3D equipment will accelerate once fee schedules catch up, but near-term volume remains anchored in 2D replacements.
Canada Mammography Market Trends and Insights
Rapid Replacement of Aging Analog Units
Hospitals that delayed digital conversions are now confronting rising service withdrawals from computed radiography hardware, forcing emergency upgrades at premium prices. Quebec eliminated its last CR system in 2023, setting a precedent for other provinces to accelerate retirements. The direct-radiography shift reduces acquisition time to 5-7 minutes per exam, boosting daily throughput by 20-25%. Vendors sweeten trade-in allowances up to 30% of the list price to win multi-unit tenders, thereby reinforcing incumbent market positions. These dynamics keep the Canada mammography market on a steady modernization path.Provincial Moves to Lower Screening Start-Age to 40 Years
Ontario, Manitoba, Saskatchewan, Newfoundland and Labrador, British Columbia, and Nova Scotia now invite average-risk women from age 40, collectively adding an estimated 1.2 million new participants. Usage at pre-existing centers in Ontario jumped to 92% before the policy shift, so overflow studies are migrating to hospitals and private clinics. Mobile strategies in Manitoba and Saskatchewan favor geographic equity over brick-and-mortar expansions. The resulting capacity squeeze gives AI-triage tools a clear value proposition. Growth pressures, therefore, concentrate demand in the Canada mammography market’s highest-throughput segments.Uneven Provincial Reimbursement for DBT and CEM Modalities
Ontario still lacks a dedicated tomosynthesis fee code, burdening hospitals with an incremental CAD 44 per exam and dampening uptake despite 2.2-point recall-rate gains. Quebec reimburses at flat bilateral rates, while BC’s cost study endorsed DBT, but no schedule change followed. Private clinics charge CAD 150-300 for uncovered 3D exams, cementing a two-tier system. Until fee structures align, reimbursement drag will cap premium-platform penetration in the Canada mammography market.Other drivers and restraints analyzed in the detailed report include:
- Federal AI-in-Health-Care Program Funding
- Public Bulk-Procurement Frameworks
- Shortage of CCPM-Certified Mammography Physicists
Segment Analysis
Full-Field Digital Mammography owned 61.83% of the Canada mammography market share in 2025, benefiting from reimbursement certainty and PACS compatibility. AI-assisted 3D systems are projected to log a 9.78% CAGR through 2031, lifted by Health Canada's 2024 clearance of Genius AI Detection and a 15-20% drop in radiologist reading time. Digital Breast Tomosynthesis occupies a clinical sweet-spot but remains fee-code-constrained in several provinces.Hospital buyers in centralized provinces have begun specifying 3D-readiness as the default, whereas in decentralized jurisdictions, units are still procured as cost-optimized 2D units, with upgrades planned later. Saskatchewan’s mobile units illustrate a throughput-first mindset, prioritizing direct radiography and satellite transfer over complex 3D stacks. As a result, the Canada mammography market size for AI-enabled 3D equipment will accelerate once fee schedules catch up, but near-term volume remains anchored in 2D replacements.
Complete Report Scope:
- By Technology
- Analog Film Mammography
- Full-Field Digital Mammography (2D)
- Digital Breast Tomosynthesis (3D)
- Contrast-Enhanced Spectral Mammography
- AI-Assisted 3D Mammography Platforms
- By End User
- Hospitals & Surgical Centres
- Dedicated Breast Screening Centres
- Diagnostic Imaging Centres
- Mobile Screening Units
- Ambulatory Care & Specialty Clinics
List of Companies Covered in this Report:
- Analogic
- Canon
- Carestream Health
- DMS Imaging SA
- FUJIFILM
- GE HealthCare Technologies Inc.
- Hologic
- Mindray Bio-Medical Electronics Co. Ltd.
- PerkinElmer
- Koninklijke Philips
- Planmed
- Samsung Medison Co. Ltd.
- Shimadzu
- Siemens Healthineers
- Varex Imaging
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
1 Introduction
4 Market Landscape
5 Market Size & Growth Forecasts
6 Competitive Landscape
7 Market Opportunities & Future Outlook
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Analogic Corporation
- Canon Medical Systems Corporation
- Carestream Health
- DMS Imaging SA
- Fujifilm Holdings Corporation
- GE HealthCare Technologies Inc.
- Hologic Inc.
- Mindray Bio-Medical Electronics Co. Ltd.
- PerkinElmer Inc.
- Philips Healthcare
- Planmed Oy
- Samsung Medison Co. Ltd.
- Shimadzu Corporation
- Siemens Healthineers AG
- Varex Imaging Corporation
